Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01235572 · ClinicalTrials.gov registry record · Phase 2
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
A Phase 2 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT01235572 is a Phase 2 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 200 participants.
The verdict
NCT01235572, a Phase 2 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
This phase II trial studies how well early discharge and outpatient care works in patients with myelodysplastic syndrome or acute myeloid leukemia previously treated with intensive chemotherapy. Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are discharged after finishing chemotherapy, or who stay in the hospital until blood counts return to normal, may help doctors learn more about the safety of allowing patients to leave the hospital early, the patient's quality of life, use of medical services, and the cost of these services associated with such a policy.
Interventions
- OTHER medical chart review
- PROCEDURE quality-of-life assessment
- PROCEDURE standard follow-up care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01235572
The ClinicalTrials.gov registry entry for NCT01235572 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT01235572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01235572 about?
NCT01235572 is a clinical study titled "Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy". This phase II trial studies how well early discharge and outpatient care works in patients with myelodysplastic syndrome or acute myeloid leukemia previously treated with intensive chemotherapy. Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are disc...
What is the current status of trial NCT01235572?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2010-12. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01235572?
The interventions under investigation include: medical chart review (OTHER), quality-of-life assessment (PROCEDURE), standard follow-up care (PROCEDURE).
Who is sponsoring clinical trial NCT01235572?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.